Aleta Biotherapeutics

About:

Aleta Biotherapeutics focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.

Website: http://www.aletabio.com/

Top Investors: Advent Life Sciences, Viva BioInnovator

Description:

Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted. The company was founded in 2015 and is headquartered in Natick, Massachusetts, United States.

Total Funding Amount:

$13.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Natick, Massachusetts, United States

Founded Date:

2015-01-01

Founders:

Paul D. Rennert, Roy Lobb

Number of Employees:

1-10

Last Funding Date:

2021-07-16

IPO Status:

Private

Industries: